martes, 1 de febrero de 2022

Trial Tests Strategy to Augment Response to COVID-19 Vaccines in Transplant Recipients | NIH: National Institute of Allergy and Infectious Diseases

Trial Tests Strategy to Augment Response to COVID-19 Vaccines in Transplant Recipients | NIH: National Institute of Allergy and Infectious Diseases
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)